(5-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDIN-2-YL)METHANOL, 95.0%, 5g

(4-((tert-Butoxycarbonyl)(methyl)amino)phenyl)boronic acid, 95.0%, 1g

(2E)-3-[4-(benzyloxy)phenyl]-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 2g

2-(3-Bromobenzyl)-3-((tert-Butoxycarbonyl)amino)propanoic acid, 97%, 500mg

Lithium sulphate monohydrate, min. 99%, pa, 500 g, plastic packaging.

2-Amino-6-(trifluoromethylthio)benzothiazole, 95.0%, 250mg

Ethyl 6-hydroxy-1H-indole-2-carboxylate, 98%, 1g

1,1,2,2-Tetra(4-carboxylphenyl)ethylene, 97%, 10g

(3R,5R)-5-Methylpyrrolidin-3-ol hydrochloride, 95.0%, 1g

(S)-2-N-Cbz-amino-succinic acid 4-methyl ester, 97.0%, 100g

6-cyclopropyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 98%, 5g

2,6-Dichloro-benzaldehyde oxime, 95.0%, 10g

Perchloric acid, 0.1 mol/l - 0.1 N standard solution, 1 l, glass packaging